Audentes Therapeutics, Inc. (BOLD) EPS Estimated At $-0.92; Reven Housing REIT (RVEN) Has 3 Sentiment

Reven Housing REIT, Inc. (NASDAQ:RVEN) Logo

Analysts expect Audentes Therapeutics, Inc. (NASDAQ:BOLD) to report $-0.92 EPS on March, 14.They anticipate $0.10 EPS change or 12.20% from last quarter’s $-0.82 EPS. After having $-0.97 EPS previously, Audentes Therapeutics, Inc.’s analysts see -5.15% EPS growth. The stock increased 0.98% or $0.23 during the last trading session, reaching $23.72. About 162,540 shares traded. Audentes Therapeutics, Inc. (NASDAQ:BOLD) has declined 19.28% since February 12, 2018 and is downtrending. It has underperformed by 19.28% the S&P500. Some Historical BOLD News: 09/05/2018 – Audentes Therapeutics at Bank of America Conference May 16; 16/05/2018 – AUDENTES ANNOUNCES CONTINUING POSITIVE DATA FROM FIRST DOSE COHORT OF ASPIRO, A PHASE 1/2 CLINICAL TRIAL OF AT132 IN PATIENTS WITH X-LINKED MYOTUBULAR MYOPATHY; 08/03/2018 – AUDENTES THERAPEUTICS INC QTRLY SHR LOSS $0.82; 08/03/2018 – Audentes Therapeutics Plans to Dose 3 Additional Patients in First Cohort of ASPIRO and Report Additional Interim Data in 2Q; 15/05/2018 – Wellington Adds Audentes Therapeutics, Exits Kindred Health; 16/05/2018 – Audentes Announces Continuing Positive Data from First Dose Cohort of ASPIRO, a Phase 1/2 Clinical Trial of AT132 in Patients W; 08/03/2018 Audentes Therapeutics 4Q Loss/Shr 82c; 15/05/2018 – Baker Bros Advisors Buys 1.1% Position in Audentes Therapeutics; 09/05/2018 – AUDENTES THERAPEUTICS INC – AT MARCH 31, 2018, AUDENTES HAD CASH, CASH EQUIVALENTS, AND SHORT-TERM INVESTMENTS OF $326.1 MLN; 16/05/2018 – AUDENTES THERAPEUTICS INC – SIGNIFICANT IMPROVEMENTS IN NEUROMUSCULAR AND RESPIRATORY FUNCTION AT 24-WEEK TIMEPOINT

Reven Housing REIT Inc (RVEN) investors sentiment increased to 3 in Q3 2018. It’s up 1.00, from 2 in 2018Q2. The ratio is better, as 3 institutional investors increased and started new holdings, while 1 sold and decreased stock positions in Reven Housing REIT Inc. The institutional investors in our database now have: 16,310 shares, down from 16,489 shares in 2018Q2. Also, the number of institutional investors holding Reven Housing REIT Inc in top ten holdings was flat from 0 to 0 for the same number . Sold All: 0 Reduced: 1 Increased: 1 New Position: 2.

Since January 1, 0001, it had 2 insider purchases, and 0 selling transactions for $27,322 activity.

More notable recent Reven Housing REIT, Inc. (NASDAQ:RVEN) news were published by: which released: “Reven Housing REIT, Inc. (RVEN) Ex-Dividend Date Scheduled for January 24, 2019 – Nasdaq” on January 23, 2019, also with their article: “Reven Housing REIT, Inc. Declares First Quarter 2019 Dividend – Business Wire” published on January 15, 2019, published: “Reven Housing REIT, Inc. Acquires 27 Additional Single-Family Homes in Oklahoma City – Business Wire” on January 03, 2019. More interesting news about Reven Housing REIT, Inc. (NASDAQ:RVEN) were released by: and their article: “Reven Housing REIT, Inc. Reports Results for Third Quarter 2018 – Business Wire” published on November 13, 2018 as well as‘s news article titled: “Reven Housing REIT, Inc. Announces Memphis, TN Portfolio Acquisition – Business Wire” with publication date: December 10, 2018.

Reven Housing REIT, Inc. acquires, owns, and operates a portfolio of occupied and rented single family residential properties in the United States. The company has market cap of $40.33 million. As of December 31, 2016, it owned 624 single family homes in the Houston, Jacksonville, Memphis, and Atlanta metropolitan areas. It currently has negative earnings. The firm intends to qualify as a real estate investment trust for federal income tax purposes.

Bank Of America Corp De holds 0% of its portfolio in Reven Housing REIT, Inc. for 88 shares. Barclays Plc owns 18 shares or 0% of their US portfolio. Moreover, Blackrock Inc. has 0% invested in the company for 477 shares. The New York-based Morgan Stanley has invested 0% in the stock. Susquehanna International Group Llp, a Pennsylvania-based fund reported 15,691 shares.

The stock increased 2.34% or $0.0843 during the last trading session, reaching $3.6843. About 557 shares traded. Reven Housing REIT, Inc. (RVEN) has declined 35.29% since February 12, 2018 and is downtrending. It has underperformed by 35.29% the S&P500. Some Historical RVEN News: 14/03/2018 Reven Housing REIT, Inc. Announces Share Repurchase Program; 02/04/2018 – Reven Housing REIT 2017 Loss $1.83M; 02/04/2018 – Reven Housing REIT, Inc. Reports Full Year 2017 Results; 02/04/2018 – Reven Housing REIT 2017 Core FFO/Share 8 Cents; 02/04/2018 – Reven Housing REIT 2017 Loss/Shr 17c; 23/04/2018 – DJ Reven Housing REIT Inc, Inst Holders, 1Q 2018 (RVEN)

More notable recent Audentes Therapeutics, Inc. (NASDAQ:BOLD) news were published by: which released: “First Week of BOLD March 15th Options Trading – Nasdaq” on February 08, 2019, also with their article: “The 7 Best Video Game Stocks to Power Up Your Portfolio! – Nasdaq” published on February 12, 2019, published: “Domino’s Has a Bold Stunt for the Big Game – Nasdaq” on February 01, 2019. More interesting news about Audentes Therapeutics, Inc. (NASDAQ:BOLD) were released by: and their article: “Smith & Nephew $3 bln spinal deal is a backbreaker – Nasdaq” published on February 11, 2019 as well as‘s news article titled: “Lebanon agrees new government, PM vows bold reforms – Nasdaq” with publication date: January 31, 2019.

Reven Housing REIT, Inc. (NASDAQ:RVEN) Institutional Positions Chart